ライフサイエンスコーパス: terbutaline

1 ease 11 L/min and 8 L/min) than those taking terbutaline.

2 e randomly assigned formoterol 4.5 microg or terbutaline 0.5 mg as needed by Turbuhaler in daily dose

3 5 microg provided better asthma control than terbutaline 0.5 mg in patients requiring moderate doses

4 horbol 12-myristate 13-acetate (PMA, 10 nM), terbutaline (0.1 mM), or ATP (1 mM), the binding of SP-A

5 voked NO release (isoproterenol; dobutamine; terbutaline; 10(-9) to 10(-5) m) was blocked by the NOS

6 ol eyes spiked with salbutamol (100 ppb) and terbutaline (25-100 ppb).

7 Terbutaline (a selective beta(2)AR agonist) and ICI 118,

8 R responses in newborn rats, we administered terbutaline, a beta2AR agonist, on postnatal day 2 and e

9 ted with cAMP or the beta-adrenergic agonist terbutaline, a biphasic AQP5 response was observed.

10 ) M), the putative beta 2-adrenergic agonist terbutaline also caused preconstricted arterioles and ve

11 A regimen of terbutaline and theophylline seems to be effective proph

12 Terbutaline at 10(-6) mol/l stimulated glycerol release

13 h2 cells were exposed to the beta2AR agonist terbutaline before activation by Ag-presenting B cells.

14 Dobutamine and terbutaline, beta1- and beta2-adrenoceptor agonists, evo

15 erol, and is metabolized (bioconverted) into terbutaline by butyrylcholinesterase (BChE).

16 d for the enantiomeric separation of racemic terbutaline by capillary electrophoresis.

17 re isometric tension after administration of terbutaline (concentration range, 10(-8) to 10(-4) M), d

18 In contrast to Th1 cells, terbutaline did not affect either IL-4 production by Th2

19 to determine whether other bronchodilators (terbutaline, diltiazem, and aminophylline) relax bronchi

20 nding sites and expectedly right-shifted the terbutaline dose-response curve to 8 +/- 3 microM.

21 Epinephrine was not required at terbutaline doses of >2 microg/kg/min.

22 acting beta-agonist formoterol compared with terbutaline, each taken as needed, in patients with mode

23 rnatants, the lower level of IL-2 present in terbutaline-exposed culture supernatants supported the p

24 Terbutaline exposure of Th1 cells before activation inhi

25 When Th clones were exposed to terbutaline following anti-CD3 activation, Th1 cell, but

26 pre-exposed to Ag and/or the beta 2AR ligand terbutaline for 24 h before being activated by either a

27 The antagonist propranolol competed with terbutaline for beta2AR binding sites and expectedly rig

28 beta2AR agonists isoproterenol and terbutaline increased basal AC activity with EC50s of 2.

29 acellular cAMP were similar in both subsets, terbutaline induced an increase in cAMP levels in Th1 ce

30 ntagonist atenolol (10(-6) M) did not affect terbutaline-induced dilation in preconstricted arteriole

31 beta2-adrenergic stimulation was produced by terbutaline infusion in three additional baboons.

32 azathioprine, ciclosporin, and subcutaneous terbutaline infusions.

33 ist, butoxamine, suggests that the effect of terbutaline is mediated by activation of beta2-adrenergi

34 hese structurally related bronchodilators is terbutaline; it is administered as a prodrug, bambuterol

35 > .05) was the most efficacious, followed by terbutaline (maximum relaxation, 72%+/-13% [proximal], 5

36 2)-adrenergic receptor ligands (epinephrine, terbutaline, metaproterenol, salmeterol, propranolol, al

37 Pups were injected with terbutaline on postnatal days 2-5.

38 e magnitude of CPK-MB concentrations and the terbutaline or epinephrine doses used.

39 hythmias were rare and not related to either terbutaline or epinephrine doses.

40 ells to either the beta 2AR-selective ligand terbutaline or the sympathetic neurotransmitter norepine

41 Oral terbutaline plus aminophylline or theophylline.

42 The beta-adrenergic agonist terbutaline produced changes in AQP5 abundance in mouse

43 ing beta2-agonists albuterol, fenoterol, and terbutaline provide rapid as-needed symptom relief and s

44 However, terbutaline relaxed the distal airway more than the prox

45 Either maternal stress or terbutaline resulted in autistic-like behaviors in offsp

46 of dobutamine (selective beta1-agonist) and terbutaline (selective beta2-agonist) on glycerol releas

47 The results demonstrate that only terbutaline showed a differential airway relaxant effect

48 Terbutaline significantly lowered DBP when used between

49 ntratracheal PBS than normal lungs following terbutaline stimulation ex vivo.

50 vivo tests using zebrafish models found that terbutaline sulfate prevents defects in axons and neurom

51 A therapeutic potential of terbutaline sulfate was also observed when axonal and ne

52 Interestingly, the prediction suggests that terbutaline sulfate, which is widely used for asthma, is

53 Terbutaline (TERB) and isoproterenol (ISO) increased lun

54 influence the SVR response to ADRB2 agonist terbutaline (Terb) during ganglionic blockade.

55 ) responses to administration of intravenous terbutaline (TRB) before and after 5 days of low dietary

56 and combined effects of maternal stress and terbutaline (used to arrest preterm labor), autism risk

57 chiral separation of milligram quantities of terbutaline using sulfated cyclodextrin as a chiral addi

58 In women, terbutaline was more effective in lean than in obese wom

59 Intravenous terbutaline was well tolerated in asthmatic children for

60 aline and adrenaline than when salbutamol or terbutaline were present (e.g., log KD propranolol -8.65

61 d of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP produc

62 atients may be treated with theophylline and terbutaline, which clinical experience suggests may redu

63 during variations in the dose of intravenous terbutaline, with or without epinephrine.

64 epinephrine > or = formoterol = fenoterol > terbutaline = zinterol = albuterol > salmeterol > dobuta